John A. Latham, Chief Scientific Officer at ALDER BIOPHARMACEUTICALS INC (ALDR), sold 4,545 shares at $32.22 ($147K) on 2015-10-01, disclosed to the SEC on 2015-10-05.
Scheduled sale ($147k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.22 | 4,300 | $139K | 94.5% |
| 2 | $32.88 | 245 | $8K | 5.5% |
| Total | $32.26 avg | 4,545 | $147K | 100% |
| Filing → |
| ALDR | SELL | 2018-09-06 | $450K | — | Filing → |
| ALDR | SELL | 2018-08-02 | $489K | — | Filing → |
| ALDR | SELL | 2018-07-03 | $387K | — | Filing → |